<DOC>
	<DOC>NCT02284516</DOC>
	<brief_summary>Evaluate the efficacy and safety of Lifitegrast in subjects with dry eye disease and a recent history of artificial tear use.</brief_summary>
	<brief_title>A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Patientreported history of Dry Eye Disease in both eyes. Use of over the counter artificial tears within the past 30 days. A negative urine pregnancy test for females and willingness to use adequate birth control throughout the study. Able and willing to comply with all study procedures. Presence of an ocular condition that could affect the study parameters such as active ocular infections, ocular inflammation, glaucoma, or diabetic retinopathy;. Unwilling to stop wearing contact lenses during the study. LASIK or other ocular surgical procedures within 12 months prior to or during the study. Use of prohibited medications Significant medical conditions that could affect the study parameters.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>